BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 12784999)

  • 1. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer.
    Netzel-Arnett S; Hooper JD; Szabo R; Madison EL; Quigley JP; Bugge TH; Antalis TM
    Cancer Metastasis Rev; 2003; 22(2-3):237-58. PubMed ID: 12784999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-anchored serine proteases in health and disease.
    Antalis TM; Bugge TH; Wu Q
    Prog Mol Biol Transl Sci; 2011; 99():1-50. PubMed ID: 21238933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a subgroup of glycosylphosphatidylinositol-anchored tryptases.
    Wong GW; Stevens RL
    Biochem Biophys Res Commun; 2005 Oct; 336(2):579-84. PubMed ID: 16143303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden.
    Martin EW; Buzza MS; Driesbaugh KH; Liu S; Fortenberry YM; Leppla SH; Antalis TM
    Oncotarget; 2015 Oct; 6(32):33534-53. PubMed ID: 26392335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type II transmembrane serine proteases in cancer and viral infections.
    Choi SY; Bertram S; Glowacka I; Park YW; Pöhlmann S
    Trends Mol Med; 2009 Jul; 15(7):303-12. PubMed ID: 19581128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface-anchored serine proteases in cancer progression and metastasis.
    Martin CE; List K
    Cancer Metastasis Rev; 2019 Sep; 38(3):357-387. PubMed ID: 31529338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobin/TMPRSS11c, a novel type II transmembrane serine protease that cleaves fibroblast growth factor-2 in vitro.
    Stallmach R; Gloor SM
    Biochem J; 2008 May; 412(1):81-91. PubMed ID: 18215125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression.
    Pawar NR; Buzza MS; Antalis TM
    Cancer Res; 2019 Jan; 79(2):301-310. PubMed ID: 30610085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of type II transmembrane serine protease-mediated signaling in cancer.
    Tanabe LM; List K
    FEBS J; 2017 May; 284(10):1421-1436. PubMed ID: 27870503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.
    Antalis TM; Buzza MS; Hodge KM; Hooper JD; Netzel-Arnett S
    Biochem J; 2010 Jun; 428(3):325-46. PubMed ID: 20507279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic activation of the protease-activated receptor (PAR)-2 by the glycosylphosphatidylinositol-anchored serine protease testisin.
    Driesbaugh KH; Buzza MS; Martin EW; Conway GD; Kao JP; Antalis TM
    J Biol Chem; 2015 Feb; 290(6):3529-41. PubMed ID: 25519908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II transmembrane serine proteases.
    Szabo R; Wu Q; Dickson RB; Netzel-Arnett S; Antalis TM; Bugge TH
    Thromb Haemost; 2003 Aug; 90(2):185-93. PubMed ID: 12888865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-anchored proteases in endothelial cell biology.
    Antalis TM; Conway GD; Peroutka RJ; Buzza MS
    Curr Opin Hematol; 2016 May; 23(3):243-52. PubMed ID: 26906027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity.
    Szabo R; Netzel-Arnett S; Hobson JP; Antalis TM; Bugge TH
    Biochem J; 2005 Aug; 390(Pt 1):231-42. PubMed ID: 15853774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type II transmembrane serine protease (TTSP) deregulation in cancer.
    Webb SL; Sanders AJ; Mason MD; Jiang WG
    Front Biosci (Landmark Ed); 2011 Jan; 16(2):539-52. PubMed ID: 21196187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type II transmembrane serine proteases in development and disease.
    Szabo R; Bugge TH
    Int J Biochem Cell Biol; 2008; 40(6-7):1297-316. PubMed ID: 18191610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family.
    Kyrieleis OJ; Huber R; Ong E; Oehler R; Hunter M; Madison EL; Jacob U
    FEBS J; 2007 Apr; 274(8):2148-60. PubMed ID: 17388811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-anchored serine proteases in vertebrate cell and developmental biology.
    Szabo R; Bugge TH
    Annu Rev Cell Dev Biol; 2011; 27():213-35. PubMed ID: 21721945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The type II transmembrane serine protease, matriptase-2: Possible links to cancer?
    Sanders AJ; Webb SL; Parr C; Mason MD; Jiang WG
    Anticancer Agents Med Chem; 2010 Jan; 10(1):64-9. PubMed ID: 20015002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of a transmembrane-type serine protease from rat kidney, a new sodium channel activator.
    Okumura Y; Nishikawa M; Cui P; Shiota M; Nakamura Y; Adachi M; Kitamura K; Tomita K; Kido H
    Biol Chem; 2003; 384(10-11):1483-95. PubMed ID: 14669991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.